Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism

被引：0
|
作者：
Catarino, R.
Pereira, D.
Pinto, D.
Matos, A.
Craveiro, R.
Lopes, C.
Medeiros, R.
机构：
[1] Portuguese Inst Oncol, Mol Oncol Unit, Oporto, Portugal
[2] Portuguese Inst Oncol, Med Oncol Dept 1, Oporto, Portugal
[3] Julio Dinis Matern, Dept Gynaecol, Oporto, Portugal
[4] Portuguese Inst Oncol, Dept Radiobiol, Oporto, Portugal
[5] Portuguese Inst Oncol, Oporto, Portugal
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：47 / 48
页数：2
相关论文
共 50 条
  • [41] Association of Cyclin D1. A870G polymorphism with two malignancies: Acute lymphoblastic leukemia and breast cancer
    Bedewy, A. M. L.
    Mostafa, M. H.
    Saad, A. A.
    El-Maghraby, S. M.
    Bedewy, M. M. L.
    Hilal, A. M.
    Kandil, L. S.
    JOURNAL OF BUON, 2013, 18 (01): : 227 - 238
  • [42] IS THERE ANY CORRELATION BETWEEN CYCLIN D1 G870A POLYMORPHISM AND GASTRIC CANCER RISK IN TURKISH PATIENTS
    Yaylim-Eraltan, Ilhan
    Ergen, H. Arzu
    Arikan, Soykan
    Agachan, Bedia
    Yildiz, Yemliha
    Gormus, Uzay
    Isbir, Turgay
    IUBMB LIFE, 2009, 61 (03) : 352 - 352
  • [43] Cyclin D1 Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human populations:: A meta-analysis
    Pabalan, Noel
    Bapat, Bharati
    Sung, Lillian
    Jarjanazi, Hamdi
    Francisco-Pabalan, Ofelia
    Ozcelik, Hilmi
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (10) : 2773 - 2781
  • [44] Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer
    Ito, M
    Habuchi, T
    Watanabe, J
    Higashi, S
    Nishiyama, H
    Wang, LZ
    Tsuchiya, N
    Kamoto, T
    Ogawa, O
    UROLOGY, 2004, 64 (01) : 74 - 78
  • [45] Cyclin D1 G870A Polymorphism and Risk of Nasopharyngeal Carcinoma: A Meta-Analysis
    Li, Meng
    Dai, Weijian
    Zhou, Huanqin
    SCIENTIFIC WORLD JOURNAL, 2013,
  • [46] The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer
    LaBonte, M. J.
    Wilson, P. M.
    Yang, D.
    Zhang, W.
    Ladner, R. D.
    Ning, Y.
    Gerger, A.
    Bohanes, P. O.
    Benhaim, L.
    El-khoueiry, R.
    El-khoueiry, A.
    Lenz, H. -J.
    ANNALS OF ONCOLOGY, 2012, 23 (06) : 1455 - 1464
  • [47] Cyclin D1 polymorphism and increased risk of colorectal cancer at young age
    Kong, SM
    Wei, QY
    Amos, CI
    Lynch, PM
    Levin, B
    Zong, JH
    Frazier, ML
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (14): : 1106 - 1108
  • [48] Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case control study in north Indian population
    Satinder, Kaur
    Chander, Sobti Ranbir
    Pushpinder, Kaur
    Indu, Gupta
    Veena, Jain
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2008, 315 (1-2) : 151 - 157
  • [49] Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case control study in north Indian population
    Kaur Satinder
    Sobti Ranbir Chander
    Kaur Pushpinder
    Gupta Indu
    Jain Veena
    Molecular and Cellular Biochemistry, 2008, 315 : 151 - 157
  • [50] Association of the cyclin D1 gene G870A polymorphism with susceptibility to sporadic renal cell carcinoma
    Narita, S
    Yu, JG
    Tsuchiya, N
    Nakamura, E
    Horikawa, Y
    Matsuura, S
    Satoh, S
    Ogawa, S
    Habuchi, T
    JOURNAL OF UROLOGY, 2005, 173 (04): : 103 - 103
12345